Indaptus TherapeuticsINDP
13F holders, Q2 2026 (June 30)9holders +3
6new positions
2sold out
1famous investor
$3.00avg. 13F price*
At the end of Q2 2026, 9 institutions reported holding Indaptus Therapeutics Inc. (INDP) in their 13F filings, up 3 from Q1 2026. 6 opened new positions and 2 sold out. The largest holders were HRT Financial LP ($618K), Geode Capital Management, LLC ($169K) and Jane Street Group, LLC ($161K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Indaptus Therapeutics Inc.
- CUSIP
- 45339J204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $958K |
| Exits | 2 | $74K |
All 13F filers, Q1 2026 → Q2 2026: 355,273 shares bought and 40,908 shares sold, net +314,365 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| HRT Financial LP | 0.00% | New | 206,077 | $618K |
| Geode Capital Management, LLC | 0.00% | Add +109.1% | 56,470 | $169K |
| Jane Street Group, LLC | 0.00% | New | 53,811 | $161K |
| Vanguard Capital Management LLC | 0.00% | New | 33,652 | $101K |
| Vanguard Fiduciary Trust Co. | 0.00% | New | 13,967 | $42K |
| Millennium Management | 0.00% | New | 11,586 | $35K |
| Morgan Stanley | 0.00% | Add +231.3% | 8,936 | $27K |
| UBS Group AG | 0.00% | New | 478 | $1K |
| SBI Securities Co., Ltd. | 0.00% | No change | 17 | $51 |
"% of holder's portfolio" is INDP's weight in each manager's 13F, not the share of Indaptus Therapeutics Inc. the manager owns.